APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Live Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Swine Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchSwine Live Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Live Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Swine Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Live Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Live Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Swine Live Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Live Vaccine include Boehringer Ingelheim, Ceva Corporate, KM Biologics, Nisseiken, DHN, Harbin Pharmaceutical Group Bio-vaccine, Jinyu Biotechnology, Qindao Lijian Bio-Tech and Shenzhen BIOCBD Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Live Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Live Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Live Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Live Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Live Vaccine Segment by Company

Boehringer Ingelheim

Ceva Corporate

KM Biologics

Nisseiken

DHN

Harbin Pharmaceutical Group Bio-vaccine

Jinyu Biotechnology

Qindao Lijian Bio-Tech

Shenzhen BIOCBD Biotechnology

Wuhan Keqian Biology

Zhongmu Industry

Swine Live Vaccine Segment by Type

Swine Fever Vaccine

Porcine Reproductive and Respiratory Syndrome Vaccine

Pseudorabies Vaccine

Others

Swine Live Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Live Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Live Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Live Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Live Vaccine Industry Trends Table 2. Swine Live Vaccine Industry Drivers Table 3. Swine Live Vaccine Industry Opportunities and Challenges Table 4. Swine Live Vaccine Industry Restraints Table 5. Global Swine Live Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Live Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Live Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Swine Live Vaccine Sales Market Share by Manufacturers Table 9. Global Swine Live Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Swine Live Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Live Vaccine Manufacturers, Product Type & Application Table 13. Global Swine Live Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Live Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Swine Fever Vaccine Table 17. Major Manufacturers of Porcine Reproductive and Respiratory Syndrome Vaccine Table 18. Major Manufacturers of Pseudorabies Vaccine Table 19. Major Manufacturers of Others Table 20. Global Swine Live Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Swine Live Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Swine Live Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Swine Live Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Swine Live Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Swine Live Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Swine Live Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Swine Live Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Breeding Farm Table 31. Major Manufacturers of Veterinary Clinic Table 32. Global Swine Live Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Swine Live Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Swine Live Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Swine Live Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Swine Live Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Swine Live Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Swine Live Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Swine Live Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Swine Live Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Swine Live Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Swine Live Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Swine Live Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Swine Live Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Swine Live Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Swine Live Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Swine Live Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Swine Live Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Swine Live Vaccine Revenue Market Share by Region (2027-2032) Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Swine Live Vaccine Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. Ceva Corporate Company Information Table 70. Ceva Corporate Business Overview Table 71. Ceva Corporate Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ceva Corporate Swine Live Vaccine Product Portfolio Table 73. Ceva Corporate Recent Development Table 74. KM Biologics Company Information Table 75. KM Biologics Business Overview Table 76. KM Biologics Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. KM Biologics Swine Live Vaccine Product Portfolio Table 78. KM Biologics Recent Development Table 79. Nisseiken Company Information Table 80. Nisseiken Business Overview Table 81. Nisseiken Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Nisseiken Swine Live Vaccine Product Portfolio Table 83. Nisseiken Recent Development Table 84. DHN Company Information Table 85. DHN Business Overview Table 86. DHN Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. DHN Swine Live Vaccine Product Portfolio Table 88. DHN Recent Development Table 89. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 90. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 91. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio Table 93. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 94. Jinyu Biotechnology Company Information Table 95. Jinyu Biotechnology Business Overview Table 96. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Jinyu Biotechnology Swine Live Vaccine Product Portfolio Table 98. Jinyu Biotechnology Recent Development Table 99. Qindao Lijian Bio-Tech Company Information Table 100. Qindao Lijian Bio-Tech Business Overview Table 101. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio Table 103. Qindao Lijian Bio-Tech Recent Development Table 104. Shenzhen BIOCBD Biotechnology Company Information Table 105. Shenzhen BIOCBD Biotechnology Business Overview Table 106. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio Table 108. Shenzhen BIOCBD Biotechnology Recent Development Table 109. Wuhan Keqian Biology Company Information Table 110. Wuhan Keqian Biology Business Overview Table 111. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Wuhan Keqian Biology Swine Live Vaccine Product Portfolio Table 113. Wuhan Keqian Biology Recent Development Table 114. Zhongmu Industry Company Information Table 115. Zhongmu Industry Business Overview Table 116. Zhongmu Industry Swine Live Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Zhongmu Industry Swine Live Vaccine Product Portfolio Table 118. Zhongmu Industry Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Swine Live Vaccine Distributors List Table 122. Swine Live Vaccine Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Swine Live Vaccine Product Image Figure 2. Global Swine Live Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Live Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Live Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Swine Live Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Live Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Swine Fever Vaccine Image Figure 9. Porcine Reproductive and Respiratory Syndrome Vaccine Image Figure 10. Pseudorabies Vaccine Image Figure 11. Others Image Figure 12. Global Swine Live Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Swine Live Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Swine Live Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Swine Live Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Swine Live Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Swine Live Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Breeding Farm Image Figure 19. Veterinary Clinic Image Figure 20. Global Swine Live Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Swine Live Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Swine Live Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Swine Live Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Swine Live Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Swine Live Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Swine Live Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Swine Live Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Swine Live Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Swine Live Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Swine Live Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Swine Live Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Swine Live Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Swine Live Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Swine Live Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Swine Live Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Swine Fever Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine
  • Pseudorabies Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Boehringer Ingelheim
  • Ceva Corporate
  • KM Biologics
  • Nisseiken
  • DHN
  • Harbin Pharmaceutical Group Bio-vaccine
  • Jinyu Biotechnology
  • Qindao Lijian Bio-Tech
  • Shenzhen BIOCBD Biotechnology
  • Wuhan Keqian Biology
  • Zhongmu Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Live Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Live Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Live Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Live Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Live Vaccine Market Dynamics
  1. 2.1 Swine Live Vaccine Industry Trends
  2. 2.2 Swine Live Vaccine Industry Drivers
  3. 2.3 Swine Live Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Live Vaccine Industry Restraints
3 Swine Live Vaccine Market by Manufacturers
  1. 3.1 Global Swine Live Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Live Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Live Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Live Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Live Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Live Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Swine Live Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Live Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Live Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Live Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Live Vaccine Market by Type
  1. 4.1 Swine Live Vaccine Type Introduction
  2. 4.1.1 Swine Fever Vaccine
  3. 4.1.2 Porcine Reproductive and Respiratory Syndrome Vaccine
  4. 4.1.3 Pseudorabies Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Swine Live Vaccine Sales by Type
  7. 4.2.1 Global Swine Live Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Swine Live Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Swine Live Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Swine Live Vaccine Revenue by Type
  11. 4.3.1 Global Swine Live Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Swine Live Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Swine Live Vaccine Revenue Market Share by Type (2021-2032)
5 Swine Live Vaccine Market by Application
  1. 5.1 Swine Live Vaccine Application Introduction
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Live Vaccine Sales by Application
  5. 5.2.1 Global Swine Live Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Live Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Swine Live Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Swine Live Vaccine Revenue by Application
  9. 5.3.1 Global Swine Live Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Live Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Swine Live Vaccine Revenue Market Share by Application (2021-2032)
6 Global Swine Live Vaccine Sales by Region
  1. 6.1 Global Swine Live Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Live Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Live Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Live Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Live Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Live Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Live Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Live Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Live Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Live Vaccine Revenue by Region
  1. 7.1 Global Swine Live Vaccine Revenue by Region
  2. 7.1.1 Global Swine Live Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Live Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Live Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Live Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Live Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Live Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Live Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Live Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Live Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva Corporate
  8. 8.2.1 Ceva Corporate Company Information
  9. 8.2.2 Ceva Corporate Business Overview
  10. 8.2.3 Ceva Corporate Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Corporate Swine Live Vaccine Product Portfolio
  12. 8.2.5 Ceva Corporate Recent Developments
  13. 8.3 KM Biologics
  14. 8.3.1 KM Biologics Company Information
  15. 8.3.2 KM Biologics Business Overview
  16. 8.3.3 KM Biologics Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 KM Biologics Swine Live Vaccine Product Portfolio
  18. 8.3.5 KM Biologics Recent Developments
  19. 8.4 Nisseiken
  20. 8.4.1 Nisseiken Company Information
  21. 8.4.2 Nisseiken Business Overview
  22. 8.4.3 Nisseiken Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nisseiken Swine Live Vaccine Product Portfolio
  24. 8.4.5 Nisseiken Recent Developments
  25. 8.5 DHN
  26. 8.5.1 DHN Company Information
  27. 8.5.2 DHN Business Overview
  28. 8.5.3 DHN Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DHN Swine Live Vaccine Product Portfolio
  30. 8.5.5 DHN Recent Developments
  31. 8.6 Harbin Pharmaceutical Group Bio-vaccine
  32. 8.6.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  33. 8.6.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  34. 8.6.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
  36. 8.6.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  37. 8.7 Jinyu Biotechnology
  38. 8.7.1 Jinyu Biotechnology Company Information
  39. 8.7.2 Jinyu Biotechnology Business Overview
  40. 8.7.3 Jinyu Biotechnology Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
  42. 8.7.5 Jinyu Biotechnology Recent Developments
  43. 8.8 Qindao Lijian Bio-Tech
  44. 8.8.1 Qindao Lijian Bio-Tech Company Information
  45. 8.8.2 Qindao Lijian Bio-Tech Business Overview
  46. 8.8.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
  48. 8.8.5 Qindao Lijian Bio-Tech Recent Developments
  49. 8.9 Shenzhen BIOCBD Biotechnology
  50. 8.9.1 Shenzhen BIOCBD Biotechnology Company Information
  51. 8.9.2 Shenzhen BIOCBD Biotechnology Business Overview
  52. 8.9.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
  54. 8.9.5 Shenzhen BIOCBD Biotechnology Recent Developments
  55. 8.10 Wuhan Keqian Biology
  56. 8.10.1 Wuhan Keqian Biology Company Information
  57. 8.10.2 Wuhan Keqian Biology Business Overview
  58. 8.10.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
  60. 8.10.5 Wuhan Keqian Biology Recent Developments
  61. 8.11 Zhongmu Industry
  62. 8.11.1 Zhongmu Industry Company Information
  63. 8.11.2 Zhongmu Industry Business Overview
  64. 8.11.3 Zhongmu Industry Swine Live Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
  66. 8.11.5 Zhongmu Industry Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Live Vaccine Value Chain Analysis
  2. 9.1.1 Swine Live Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Live Vaccine Production Mode & Process
  6. 9.2 Swine Live Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Live Vaccine Distributors
  9. 9.2.3 Swine Live Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst